Osaic Holdings
BXRX

Osaic Holdings’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Osaic Holdings’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22
Closed -$6 – 7643
2023
Q3 		$6 Hold
22
– – ﹤0.01% 7350
2023
Q2 		$24 Hold
22
– – ﹤0.01% 7366
2023
Q1 		$35 Hold
22
– – ﹤0.01% 7399
2022
Q4 		$0 Sell
22
-2
-8% -$12 ﹤0.01% 7771
2022
Q3 		$0 Sell
24
-6
-20% -$140 ﹤0.01% 7808
2022
Q2 		$1K Hold
30
– – ﹤0.01% 7257
2022
Q1 		$2K Sell
30
-7
-19% -$1.29K ﹤0.01% 6971
2021
Q4 		$11K Buy
37
+3
+9% +$1.88K ﹤0.01% 6223
2021
Q3 		$26K Hold
34
– – ﹤0.01% 5604
2021
Q2 		$35K Sell
34
-7
-17% -$9.16K ﹤0.01% 5315
2021
Q1 		$74K Buy
41
+4
+11% +$8K ﹤0.01% 4585
2020
Q4 		$53K Buy
37
+29
+363% +$59.3K ﹤0.01% 4525
2020
Q3 		$31K Buy
8
+1
+14% +$4.53K ﹤0.01% 4655
2020
Q2 		$41K Buy
7
+4
+133% +$19.2K ﹤0.01% 4340
2020
Q1 		$11K Buy
+3
New +$28.3K ﹤0.01% 4976

Osaic Holdings's BXRX Position: Q4 2023 in Review

Osaic Holdings sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2023, closing a stake of 22 shares — an estimated $6 sold.

Osaic Holdings first reported a position in BXRX in Q1 2020 and held it in 15 quarters. The position peaked at $74K in Q1 2021. 2 funds tracked by Wall St. Rank hold BXRX as of Q4 2023.

  • Osaic Holdings reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 22 Baudax Bio, Inc. Common Stock shares in Q4 2023, an estimated $6.
  • Osaic Holdings first reported a position in Baudax Bio, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
  • Osaic Holdings's Baudax Bio, Inc. Common Stock position peaked at $74K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.